Last Updated on August 10, 2023 by The Health Master
Export of Cough Syrups
The Small and Medium Pharma Manufacturers Association (SMPMA) is urging Indian regulatory authorities, specifically the Drugs Controller General of India (DCGI) and the Directorate General of Foreign Trade (DGFT), to expedite the export of cough syrups from India.
This plea comes in response to the growing threat of losing business to China in the global market.
Leveraging National Accreditation for Swift Exports
To combat this challenge, the SMPMA is proposing a solution that involves the utilization of Certificates of Analysis (COA) issued by NABL-accredited private testing laboratories in India.
By allowing the export of cough syrups based on COAs from these accredited labs, the association believes that India can effectively protect its market share against China’s exports.
SMPMA Advocates for Action
Nipun Jain, Chairman of SMPMA, emphasizes the urgency of this matter. He asserts that allowing the export of cough syrups based on COAs issued by NABL accredited private labs would be a speedy solution to the issue.
Jain also calls for the DGFT to grant permission for multiple accredited private labs across India to meet the demands of exporters promptly.
This move, he believes, would enable exporters to ensure timely testing and issuance of COAs, benefiting overall export activities.
Bridging the Gap and Staying Competitive
The SMPMA is dedicated to enhancing its competitive stance to seize opportunities in pharmaceutical exports, including cough syrups.
Recognizing that countries like China are progressing in their export endeavors due to faster clearance processes, SMPMA is advocating for a solution that streamlines the testing and certification process.
Government Regulation and Industry Challenges
DGFT’s notification dated May 22, 2023, and the corresponding instructions from the DCGI mandate that cough syrups intended for export undergo mandatory testing by accredited government laboratories to obtain COAs before shipping.
However, the SMPMA points out that these accredited government labs are currently experiencing significant backlogs, leading to prolonged delays in export clearances.
Impact on Export Performance
The delays in clearance from accredited government laboratories have been detrimental to the export performance of the pharmaceutical sector.
These setbacks are causing export orders to be canceled due to agreement timelines not being met or cough syrups reaching their shelf-life cutoff before being shipped.
Taking Action for the Industry’s Growth
The SMPMA’s plea to the regulatory authorities is driven by the industry’s urgent need for streamlined processes.
By enabling the use of COAs from NABL accredited private testing labs for exports, the association aims to bolster the pharmaceutical sector’s export activities and secure India’s position in the global market, while avoiding losing ground to competitors like China.
Disclaimer: This article contains information derived from the source mentioned below. Our team utilized an AI language model, to rewrite and present the news / article in a unique format.
DCGI asks manufacturers: Not to submit same batch of cough syrup to multiple Laboratories
Pharma Industry urges Govt to authorize Private labs to test cough syrups
DTAB: Examination of RMP requirement for sale of Cough Syrups
CDSCO implements transparent reporting system for Cough Syrup exports
Quality Assurance Vs Quality Control in the Pharma Industry
Major FDA audit findings about Equipment and Instruments
Understanding GMP, cGMP, and WHO-GMP
Quality Assurance in the Pharmaceutical Industry
Duties and responsibilities of QA person in Pharma Industry
Difference: Disintegration and Dissolution test in pharma industry
Understanding DQ, IQ, PQ, and OQ in the Pharma Industry
NABL: List of NABL Accredited Testing Laboratories
NABL 164 released : Guidelines for Inter-laboratory comparison
NABL releases NABL 136: specific criteria for X-Ray equipment
NABL 126: Specific criteria for calibration of Medical Devices
CDSCO initiates training for Medical Device Officers to implement MDR 2017
USFDA gives approval for this Skin and Bone Infections Drug
Pharma Industry’s heavy reliance on Chinese Bulk Drug imports sparks concerns
USFDA issues warning letter to Intas Pharmaceuticals
Tax Dept uncovers Rs 6 Crore Tax Evasion in Pharma Companies: Uttrakhand
Govt extends implementation date for Track and Trace System in Drug Exports
Stakeholders urge Govt to recall New Drugs, Cosmetics & Medical Devices Bill
Gujarat FDCA takes stringent actions against Non-Compliant Pharma Companies
Major Crackdown: Rs 2 Crore-worth counterfeit drugs seized in Kolkata
For informative videos by The Health Master, click on the below YouTube icon:
For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:
For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:
For informative videos on consumer awareness, click on the below YouTube icon:
